Dr. Michael D. Hall, MD

Dr. Hall practices at Caduceus Medical Group in Yorba Linda, California.

Dr. Hall's NPI, 1487695706, was assigned on June 9, 2006. Dr. Hall graduated from Loma Linda University School Of Medicine in 1988. Dr. Hall holds California license G66822.

Dr. Hall's primary practice is Caduceus Medical Group, at 18200 Yorba Linda Blvd, Yorba Linda, CA 92886. The practice phone is (949) 499-0577.

Dr. Hall's primary practice is Caduceus Medical Group in Yorba Linda, California. Dr. Hall is also affiliated with UCI Health - Orange. The medical group on file is Caduceus Medical Group. Dmand AI also links Dr. Hall to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Hall's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hall practices, 5 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Hall's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Hall is board certified in family medicine by the American Board of Family Medicine. Dr. Hall is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, acute sinusitis, acute skin infection, anxiety, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Hall treats.

CMS data shows 2,045 Medicare services from Dr. Hall across 27 procedure codes in 2024, for 691 Medicare patients. Medicare paid $147,900 for them. Every service was in an office.

CMS counts 691 Medicare patients who saw Dr. Hall in 2024. The largest group is 65 to 74, with 383 patients. 73% of them have high cholesterol, and 68% have high blood pressure. 9% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hall's median patient age at 58, with 52% women.

In 2024, Dr. Hall wrote 5,877 Medicare Part D claims for 610 patients. 91% of them were for generic drugs. CMS names the drug for 5,191 of them, across 101 drugs with 11 or more claims each, at $311,244 in total drug cost. In 2023, CMS named 4,794 claims across 97 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hall for performance year 2024, reported individually. Dr. Hall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hall as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 208 papers to Dr. Hall, published from 2001 to 2021. 2015 was the busiest year, with 14. The most frequent topics are Signal Transduction, TOR Serine-Threonine Kinases and Saccharomyces cerevisiae. Dr. Hall has published most often in Proc Natl Acad Sci U S A. Dr. Hall's most frequent co-authors are John F. Brown, MD, Kevin D. Burns, MD and Alessia Fornoni, MD, PhD.

CMS Open Payments shows 6 general payments to Dr. Hall from 4 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $57.

Dr. Hall graduated from Loma Linda University School Of Medicine in 1988.

Dr. Hall is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.